Three Biotechs That Takeover: Top 2026 M&A Targets
As large pharma hunts for GLP-1 and cardiovascular assets, three biotechs stand out as hot takeover targets. This rep...
Determine which IRA is best for low-cost index funds to minimize fees and maximize long-term growth across portfolios.
26,522 articlesAs large pharma hunts for GLP-1 and cardiovascular assets, three biotechs stand out as hot takeover targets. This rep...
Nvidia approaches Q1 FY2027 with lofty guidance and heightened scrutiny, as wall street holds breath awaiting whether...
A sweeping shift in government-backed tech funding is changing how investors value IBM and Intel. Taxpayers, once dis...
Claudia Sahm, a former Federal Reserve economist and creator of a recession signal, says Kevin Warsh’s policy views c...
Oil prices decline as investors weigh possible progress toward a Middle East peace agreement. Markets respond to dipl...
Xactus has completed the acquisition of Mortgage Credit Link from MeridianLink, rebranding it as XedaLink and positio...
Palantir faces a steeper path in 2026 as the stock retreats, yet bulls argue the core AI platform and government dema...
Investors are reexamining whether $40,000 can reliably produce $4,800 in annual passive income through high-yield div...
Markets brace for Kevin Warsh's first Fed meeting amid stubborn inflation and political scrutiny. Observers ask wheth...
CrowdStrike is set to report Q1 results after the close, with analysts expecting revenue around $1.39 billion and sol...
SpaceX has not announced an IPO date, but growing chatter centers on whether retail investors could drive a future pu...
Markets weigh whether will spacex’s $1.75 trillion IPO valuation can survive a Friday rout that hit growth and tech s...